Sheila Adamu

The researcher has made significant contributions to stroke research across multiple domains. Their work on acute ischemic stroke management in Ghana and Nigeria highlights the importance of interventions like phone-based blood pressure control and strokes in reducing mortality. The researcher also investigated trends in stroke admission and mortality rates from 1983 to 2013, showing a decline in complications over time. Additionally, their studies emphasized the role of telemedicine and telehealth implementation, particularly in addressing barriers faced by patients and healthcare providers. The researcher's focus on rehabilitation strategies for stroke survivors includes pilot trials of phone-based interventions under nurse guidance, such as PINGS (Phone-Based Intervention Under Nurse Guidance After Stroke), which demonstrated improved outcomes. Their work also touched on the biological aspects of stroke, including blood typing and poststroke cognitive impairment in Ghanaian stroke survivors. The researcher's research extended to chronic kidney disease and diabetes, with studies examining their interplay with stroke risk factors. Contributions to emergency care included comparative pelvimetric measurements among Nigerian and Welsh women, highlighting healthcare accessibility. Their work on medication adherence emphasized the importance of antiplatelet therapies and blood pressure control in preventing strokes. The researcher's involvement in trypanosoma research provided insights into disease dynamics and interactions with host systems. Nutrition studies examined factors associated with fruit and vegetable consumption and were also explored their impact on stroke outcomes. Their work on acute care settings included feasibility randomized trials of mobile-health delivered rehabilitation programs for Parkinson's disease survivors, underscoring the value of technology in health services. Their research on ocular impairment in stroke survivors offered clues about the mechanisms underlying visual dysfunction. The researcher's studies on hemorrhgeia focused on secondary prevention strategies with statins and aspirin. Their work on blood pressure and hyperuricaemia highlighted the role of lipid profiles in stroke risk reduction. Their contribution to parasite research included seasonal variations in Schistosoma haematobium infections, offering insights into transmission dynamics. In health policy, they explored integrating thrombolysis into stroke care models, emphasizing the need for integrated healthcare systems. Their research on ocular impairment provided critical perspectives on visual outcomes in stroke survivors. Lastly, their work on intracerebral hemorrhage examined secondary prevention strategies with statins and aspirin, underscoring the importance of early intervention. Overall, the researcher's comprehensive approach to stroke research across multiple themes has advanced our understanding of stroke prevention and management, with implications for healthcare delivery and policy implementation.